Strata Critical Medical, Inc. (SRTA) stock
Close on Nov 11, 2026Market cap $531.69MP/E 11.8Yield –
Strata Critical Medical, Inc. grew revenue 66.8% to $255.98M over the twelve months to Jun 30, 2026. Free cash flow was -$48.45M. At the latest close the market valued the company at $531.69M, 11.8 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $531.69M
- P/E ratio
- 11.8
- Price to sales
- 2.08
- Price to book
- 1.90
- Dividend yield
- –
- Free cash flow yield
- -9.11%
Fundamentals
- Revenue
- $255.98M
- Net income
- $40.22M
- EPS, diluted
- $0.51
- Free cash flow
- -$48.45M
- Book value per share
- $3.24
- Diluted shares
- 86M
Trading
- Next earnings
- Mar 2, 2027 (estimated, before the open)
- Previous close
- $6.02
- Open
- $6.03
- Day's range
- $5.96 – $6.20
- Volume
- 1,113,658
- Average volume (20 days)
- 1,276,508
- Index membership
- Russell 2000 (since Jun 2022), Russell 3000 (since Aug 2022)
- Beta (5 years)
- 1.64
- 52-week range
- $3.95 – $6.50
- RSI (14 days)
- 72.7
- Volatility (1 year)
- 56.9%
- Relative volume
- 1.11×
- WACC
- 13.1%
On 1 of our idea list: Undervalued and financially sound
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SRTA | S&P 500 | Difference | SRTA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +32.7% | -2.4% | +35.1 pts | ||
| 3 months | -0.3% | -1.2% | +0.8 pts | ||
| Year to date | +24.9% | +12.3% | +12.7 pts | ||
| 1 year | +19.2% | +12.4% | +6.8 pts | ||
| 3 years | +88.4% | +78.8% | +9.6 pts | +23.5% | +21.4% |
| 5 years | -39.7% | +75.2% | −114.8 pts | -9.6% | +11.9% |
Seven years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Strata Critical Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Update
About Strata Critical Medical
Transportation Services
Strata Critical Medical, Inc. provides time-critical logistics and specialized clinical services to the healthcare sector in the United States. Through its Logistics segment, operating under the Trinity brand, the organization arranges air and ground transport for donor organs, surgical personnel, medical equipment, and biological samples, while also offering donor organ placement coordination. Through its Clinical segment, marketed under the Keystone brand, the company provides surgical organ recovery, organ preservation, normothermic regional perfusion, and cardiac perfusion services, alongside clinical staffing and medical equipment rentals. Its services are directly contracted by organ procurement organizations, transplant centers, and cardiovascular surgery hospitals.
Company profile, executives and historyStrata Critical Medical stock: common questions
What is Strata Critical Medical's stock price?
SRTA closed at $6.01 on Nov 11, 2026, down 0.17% on the day. Over the past 52 weeks it traded between $3.95 and $6.50.
What is Strata Critical Medical's market cap?
Strata Critical Medical was worth $531.69M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is SRTA's P/E ratio?
SRTA trades at 11.8 times earnings, based on diluted earnings per share of $0.51 over the twelve months to Jun 30, 2026.
How much revenue does Strata Critical Medical make?
Strata Critical Medical reported revenue of $255.98M for the twelve months to Jun 30, 2026, up 66.8% from a year earlier.
Does Strata Critical Medical pay a dividend?
No. Strata Critical Medical has not paid a cash dividend over the last twelve months.
When does Strata Critical Medical report earnings next?
Strata Critical Medical is expected to report Q4 FY2026 results on Mar 2, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has SRTA stock performed over the past year?
Including dividends, SRTA returned +19.2% over the past year, against +12.4% for the S&P 500.
How many SRTA shares are sold short?
5M shares were sold short at the latest FINRA report, 6.51% of the float, or 5.0 days of average trading volume.
Who are Strata Critical Medical's competitors?
Companies most similar to Strata Critical Medical by business, industry and size include DCGO, VRRM, TMDX, LIND, TOUR.
See a number that looks wrong?